186 related articles for article (PubMed ID: 36059700)
1. Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma.
Li S; Liu T; Liu H; Zhai X; Cao T; Yu H; Hong W; Lin X; Li M; Huang Y; Xiao J
Front Oncol; 2022; 12():976762. PubMed ID: 36059700
[TBL] [Abstract][Full Text] [Related]
2. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
[TBL] [Abstract][Full Text] [Related]
3. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
Front Immunol; 2022; 13():829366. PubMed ID: 35371002
[TBL] [Abstract][Full Text] [Related]
4. Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Chen Z; Huang H; Huang H; Yu L; Weng H; Xiao J; Zou L; Zhang H; Liang C; Zhou H; Guo H; Wang Z; Li Z; Wu T; Zhang H; Wu H; Peng Z; Zhai L; Chen X; Liang Y; Hong H; Lin T
Leukemia; 2024 Apr; 38(4):829-839. PubMed ID: 38378844
[TBL] [Abstract][Full Text] [Related]
5. Advances in multiple omics of natural-killer/T cell lymphoma.
Xiong J; Zhao WL
J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
7. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.
Liu ZL; Bi XW; Zhang XW; Lei DX; Liu PP; Yang H; Gao Y; Jiang YX; Jiang WQ; Xia Y
Cancer Res Treat; 2019 Oct; 51(4):1557-1567. PubMed ID: 30971067
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Shi Z; Li X; Wang X; Zhang L; Li L; Fu X; Sun Z; Li Z; Zhang X; Zhang M
Front Cell Infect Microbiol; 2021; 11():686595. PubMed ID: 34568086
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.
Sui X; Zhang C; Jiang Y; Zhou J; Xu C; Tang F; Chen B; Xu H; Wang S; Wang X
Ann Transl Med; 2020 Jun; 8(11):688. PubMed ID: 32617308
[TBL] [Abstract][Full Text] [Related]
12. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
13. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
[TBL] [Abstract][Full Text] [Related]
14. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential.
Xiong J; Wang N; Zhong HJ; Cui BW; Cheng S; Sun R; Chen JY; Xu PP; Cai G; Wang L; Sun XJ; Huang JY; Zhao WL
EBioMedicine; 2021 Oct; 72():103614. PubMed ID: 34628354
[TBL] [Abstract][Full Text] [Related]
15. Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
Chai Y; Qi F; Chen B; Gui L; Yang J; Qi S; Song Y; Li Y; Wei Y; Dong M
Ann Hematol; 2020 Jun; 99(6):1303-1309. PubMed ID: 32333152
[TBL] [Abstract][Full Text] [Related]
16. Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel.
Choi S; Go JH; Kim EK; Lee H; Lee WM; Cho CS; Han K
Genomics Inform; 2016 Sep; 14(3):78-84. PubMed ID: 27729836
[TBL] [Abstract][Full Text] [Related]
17. Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.
Wang Z; Zhang Q; Qi C; Bai Y; Zhao F; Chen H; Li Z; Wang X; Chen M; Gong J; Peng Z; Zhang X; Cai J; Chen S; Zhao X; Shen L; Li J
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35705314
[TBL] [Abstract][Full Text] [Related]
18. What we should know about natural killer/T-cell lymphomas.
Xiong J; Zhao W
Hematol Oncol; 2019 Jun; 37 Suppl 1():75-81. PubMed ID: 31187536
[TBL] [Abstract][Full Text] [Related]
19. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
[TBL] [Abstract][Full Text] [Related]
20. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
